🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉 🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉
FDA designates Chugai's bispecific antibody as breakthrough therapy

Japan's pharma giant, Chugai Pharmaceutical Co. has reported that the US Food and Drug Administration (FDA) has granted ...

September 14, 2015 | Monday | News
NZ gets drug that glows brain tumour

Singapore: A novel drug, GLIOLAN (aminolevulinic acid HCl), that helps neurosurgeons to better visualise and remove mali...

September 21, 2015 | Monday | News
Singapore develops animal-free screening platform to predict nephrotoxicity

Singapore: Researchers from Singapore's Institute of Bioengineering and Nanotechnology (IBN) have developed an animal-fr...

October 9, 2015 | Friday | News
Shionogi's constipation drug phase III study shows significant improvement

The US subsidiary of Osaka-based Shionogi has announced results of its pivotal phase III study (COMPOSE I). The study re...

February 22, 2016 | Monday | News
LBT Innovations inks partnership with French tech firm

Singapore: Australian medical technology company, LBT Innovations, has signed a license agreement with French in vitro d...

August 27, 2015 | Thursday | News
CARsgen partners with Shanghai Cancer Institute to develop cancer immunotherapies

Singapore: China based CARsgen Therapeutics, a private and venture backed company focused on the development of CAR-T-ba...

September 30, 2015 | Wednesday | News
Actavis to acquire Forest Lab

Singapore: Actavis has recieved US Federal Trade Commission (FTC) nod to acquire Forest Laboratories following a propose...

July 1, 2014 | Tuesday | News
Phylogica appoints CEO, CSO, CFO

Singapore: Leading Australian peptide drug discovery company Phylogica appointed Dr Richard Hopkins as the company's new...

July 23, 2013 | Tuesday | News
Kowa Pharma and Eli Lilly release PK study result

Singapore: Kowa Pharmaceuticals and Eli Lilly released results from a pharmacokinetic (PK) study exploring potential dru...

July 23, 2012 | Monday | News
TWi's diabetes drug recieves patent allowance from Europe, Russia

Singapore: Taiwan based TWi Biotechnology has received patent allowance for AC-201, its lead drug candidate, from the Eu...

August 3, 2015 | Monday | News
Japanese stem cell company ReproCELL acquires Biopta

Tokyo: Japanese regenerative medicine company ReproCELL Inc. has announced the acquisition of the Scottish life science...

November 26, 2015 | Thursday | News
IBM, A*Star co-develop anti-microbial hydrogel

Singapore: Researchers from A*Star's Institute of Bioengineering and Nanotechnology (IBN) and IBM have unveiled first-e...

January 24, 2013 | Thursday | News
Pfizer launches targeted therapy for lung cancer in Singapore

Singapore: Pfizer has launched Xalkori, a targeted therapy for ALK-positive non-small cell lung cancer (NSCLC), in Singa...

August 4, 2015 | Tuesday | Regulatory
HSA nod for Aslan rheumatoid arthritis drug

Singapore: Aslan Pharmaceuticals received approval by the Singapore Health Sciences Authority (HSA) for its Clinical Tri...

April 23, 2013 | Tuesday | Regulatory
Celsion launches cancer drug trial in China

Singapore: Celsion Corporation, a fully-integrated oncology company focused on the development of a portfolio of innovat...

March 8, 2016 | Tuesday | News
China SFDA passes Sihuan Pharma's Roxatidine

Singapore: Sihuan Pharmaceutical Holdings' roxatidine acetate hydrochloride for injection (Roxatidine), which is the com...

May 28, 2012 | Monday | News
Takeda, DND to accelerate drug discovery for parasite infection

Singapore: Geneva based Drugs for Neglected Diseases and Japan's Takeda have collaborated for a Lead Optimization Progra...

July 29, 2015 | Wednesday | News
Abbott marks success with naturally dissolving stent in Japan

Global life sciences company Abbott has announced that the company has observed positive clinical results from ABSORB Ja...

September 2, 2015 | Wednesday | News